Related Experiment Videos

[Why do adults with mucoviscidosis refuse a medically recommended course of intravenous antibiotic therapy?]

G Ullrich1, C Smaczny, G Steinkamp

  • 1Abt. Pneumologie, Medizinische Hochschule Hannover, Zentrum Innere Medizin und Dermatologie.

Abstract

Insights

Many cystic fibrosis patients decline intravenous antibiotics for Pseudomonas aeruginosa infections, often due to perceived mildness of illness and fear of side effects. Understanding patient reasoning is crucial for effective treatment adherence.

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Patient Adherence

Context:

  • Chronic Pseudomonas aeruginosa (PA) infection is common in cystic fibrosis (CF) patients.
  • Intravenous (i.v.) antibiotic courses are standard treatment for chronic PA infections in CF.
  • A subgroup of adult CF patients refuse recommended i.v. antibiotic therapy.

Purpose:

  • To explore the reasons why a subgroup of adult CF patients refuse regular i.v. antibiotic treatment for chronic PA infection.
  • To understand patient perceptions of chronic PA infection and expectations of i.v. therapy.
  • To identify personal reasons for refusal of i.v. treatment.

Summary:

  • Over half of interviewed patients underestimated the importance of chronic PA infection due to asymptomatic presentation.
  • Patients often lacked understanding of their ideal clinical status and reported prior ineffective i.v. treatments.
  • Key reasons for refusal included not feeling sufficiently ill and apprehension regarding adverse drug effects.

Impact:

  • Highlights the importance of addressing patient perspectives and reasoning beyond 'non-compliance'.
  • Emphasizes the need for open dialogue to understand and influence patient decisions in CF management.
  • Suggests that exploring patient concerns is vital for improving physician-patient relationships and treatment outcomes.

Related Concept Videos